$7.12
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?
Cumberland Declares Special Dividend, Approves $5 Million Share Buyback
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
Overview
52-week range
$1.85
$6.61
100% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-0.5%
50% positive
Latest IV / EM
137%
EM ±31.3% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-0.13 | — | — | -186.7% | +0.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.13 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $0.02 | — | — | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.15 | — | — | — | -1.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.08 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.14 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.06 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | — | $0.02 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $2M | — | $988,760 | $2M | $1M | — | $1M | $2M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | — | $-2M | $-747,478 | $1M | — | $-2M | $-1M |
| Net income | $-3M | — | $-2M | $-740,740 | $1M | — | $-2M | $-1M |
| EPS (diluted) | $-0.22 | — | $-0.13 | $-0.05 | $0.08 | — | $-0.11 | $-0.08 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $11M | $15M | $16M | $15M | $18M | $17M | $17M |
| Inventory | $5M | $6M | $3M | $3M | $4M | $4M | $5M | $4M |
| Total current assets | $33M | $37M | $30M | $31M | $32M | $36M | $35M | $36M |
| Total assets | $71M | $77M | $66M | $68M | $70M | $76M | $77M | $79M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $50M | $52M | $40M | $40M | $42M | $53M | $52M | $52M |
| Total equity | $22M | $25M | $26M | $28M | $29M | $23M | $25M | $26M |